Stocks of the Hour: Golden Deeps, Noxopharm, Echo IQ
Stocks of the Hour: Golden Deeps, Noxopharm, Echo IQ
Golden Deeps (ASX:GED) has announced that thick copper and zinc sulphide mineralisation has been intersected in diamond drilling of key targets at the Company's Havilah Project. The results up to 18.5% Copper & 34.8% Zinc in initial pXRF readings. Shares are trading 157.14 per cent higher at 7.2 cents.
Golden Deeps（ASX:GED）宣佈，在公司的Havilah項目的關鍵目標進行的金剛石鑽探中，已經交叉了厚厚的銅和硫化鋅礦化物。最初pXRF讀數顯示銅含量高達18.5%和鋅含量達34.8%。股價上漲157.14%，每股7.2美分。
Innovative biotech company Noxopharm (ASX:NOX) has announced substantial progress on its Chroma technology platform, with encouraging brain cancer results plus early work on leukaemia. The Chroma drug development program focuses on generating promising novel anticancer drugs. Shares are trading 23.81 per cent higher at 13 cents.
創新生物科技公司Noxopharm（ASX:NOX）宣佈其Chroma科技平台取得重大進展，取得令人鼓舞的腦癌研究成果，以及對白血病的早期工作。Chroma藥物開發計劃專注於生成有前景的新型抗癌藥物。股價上漲23.81%，每股13美分。
Echo IQ (ASX:EIQ) is pleased to provide the following overview of positive results from two recently completed clinical studies, which highlight the effectiveness of its AI-backed solution for heart failure when compared to an observed detection rate of 46% in clinical practice. Shares are trading 10 per cent higher at 16.5 cents.
Echo IQ（ASX:EIQ）很高興地介紹了最近完成的兩項臨床研究的積極結果概述，這些研究強調了其人工智能支持的心力衰竭解決方案的有效性，與臨床實踐中46%的觀測檢測率相比。股價上漲10%，每股16.5美分。
